GlobeNewswire Inc | Sep 1, 2021 08:00AM EDT

September 01, 2021

NEW YORK, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc.(Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced thatJerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research & Development and Chief Medical Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the virtual Baird 2021 Global Healthcare Conference onTuesday, September 14, 2021at10:15 a.m. ET.

A live webcast of the event will be available on the investor page of Intercepts website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercepts website for approximately two weeks.

About Intercept

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 inNew York, Intercept has operations inthe United States,EuropeandCanada. For more information, please visitwww.interceptpharma.comor connect with the company onTwitterandLinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:investors@interceptpharma.com

Media inquiries:media@interceptpharma.com